EW
TMO icon

Evoke Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Evoke Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,483
Closed -$730K – 575
2026
Q1 		$730K Sell
1,483
-142
-9% -$77.1K 0.01% 329
2025
Q4 		$942K Sell
1,625
-128
-7% -$72.4K 0.02% 277
2025
Q3 		$851K Buy
1,753
+383
+28% +$178K 0.02% 275
2025
Q2 		$556K Sell
1,370
-96
-7% -$40.1K 0.01% 327
2025
Q1 		$730K Buy
1,466
+287
+24% +$155K 0.02% 226
2024
Q4 		$614K Sell
1,179
-41
-3% -$22.5K 0.02% 233
2024
Q3 		$755K Buy
+1,220
New +$722K 0.02% 206
2024
Q2 		– Sell
-1,157
Closed -$673K – 354
2024
Q1 		$673K Buy
+1,157
New +$649K 0.02% 210
2023
Q4 		– Sell
-1,116
Closed -$565K – 322
2023
Q3 		$565K Buy
1,116
+177
+19% +$94.3K 0.02% 223
2023
Q2 		$490K Buy
939
+215
+30% +$116K 0.02% 222
2023
Q1 		$418K Sell
724
-74
-9% -$41.7K 0.02% 233
2022
Q4 		$440K Sell
798
-276
-26% -$146K 0.02% 228
2022
Q3 		$545K Sell
1,074
-123
-10% -$68.8K 0.02% 203
2022
Q2 		$651K Sell
1,197
-563
-32% -$310K 0.02% 198
2022
Q1 		$1.04M Buy
1,760
+203
+13% +$117K 0.03% 174
2021
Q4 		$1.04M Buy
1,557
+27
+2% +$16.9K 0.03% 176
2021
Q3 		$874K Sell
1,530
-90
-6% -$49.4K 0.03% 181
2021
Q2 		$818K Buy
1,620
+216
+15% +$102K 0.03% 192
2021
Q1 		$641K Buy
1,404
+723
+106% +$345K 0.03% 192
2020
Q4 		$317K Buy
681
+510
+298% +$239K 0.02% 191
2020
Q3 		$76K Buy
171
+55
+47% +$22.7K 0.01% 313
2020
Q2 		$42K Sell
116
-8
-6% -$2.68K ﹤0.01% 368
2020
Q1 		$35.2K Sell
124
-256
-67% -$80.7K 0.01% 372
2019
Q4 		$124K Buy
380
+139
+58% +$42.1K 0.02% 297
2019
Q3 		$70.2K Buy
+241
New +$69K 0.01% 421

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Evoke Wealth's TMO Position: Q2 2026 in Review

Evoke Wealth sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 1,483 shares — an estimated $730K sold.

Evoke Wealth first reported a position in TMO in Q3 2019 and held it in 25 quarters. The position peaked at $1.04M in Q1 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Evoke Wealth reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,483 Thermo Fisher Scientific shares in Q2 2026, an estimated $730K.
  • Evoke Wealth first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 25 quarters.
  • Evoke Wealth's Thermo Fisher Scientific position peaked at $1.04M in Q1 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.